ABBV-1354
- Generic Name
- ABBV-1354
A Study to Assess Change in How Oral Icalcaprant With Itraconazole Moves Through the Body in Healthy Adult Participants
- First Posted Date
- 2024-12-09
- Last Posted Date
- 2025-01-28
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 12
- Registration Number
- NCT06722430
- Locations
- 🇺🇸
Acpru /Id# 271617, Grayslake, Illinois, United States
A Single Dose Study to Assess Adverse Events and How Oral Icalcaprant Moves Through the Body in Healthy Adult Japanese and Han Chinese Participants
- First Posted Date
- 2024-12-09
- Last Posted Date
- 2025-01-28
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 16
- Registration Number
- NCT06722417
- Locations
- 🇺🇸
Anaheim Clinical Trials, LLC /ID# 271323, Anaheim, California, United States
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
Phase 2
Not yet recruiting
- Conditions
- Bipolar I DisorderBipolar II Disorder
- Interventions
- Drug: Placebo for Icalcaprant
- First Posted Date
- 2024-11-20
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 237
- Registration Number
- NCT06696755
Positron Emission Tomography (PET) Trial to Evaluate Target Occupancy of CVL-354 at Kappa and Mu Opioid Receptors in Brain Following Oral Dosing
Phase 1
Completed
- Conditions
- Opioid Use Disorder
- Interventions
- First Posted Date
- 2022-09-21
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- Cerevel Therapeutics, LLC
- Target Recruit Count
- 19
- Registration Number
- NCT05547542
- Locations
- 🇺🇸
New Haven, Connecticut, New Haven, Connecticut, United States
🇺🇸Yale PET Center, New Haven, Connecticut, United States
A Single and Multiple Ascending Dose Trial of CVL-354 in Healthy Participants
- First Posted Date
- 2021-12-01
- Last Posted Date
- 2024-11-26
- Lead Sponsor
- Cerevel Therapeutics, LLC
- Target Recruit Count
- 73
- Registration Number
- NCT05138653
- Locations
- 🇺🇸
Labcorp Drug Development, Dallas, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath